Stephen Russell, a former Mayo Clinic researcher and CEO of Vyriad, reveals groundbreaking insights into the measles virus and its unexpected potential as a cancer treatment. Russell discusses how measles can induce immune responses that may aid in tumor remission. He also explores the concept of 'immune amnesia' caused by measles, shedding light on its complex interaction with other infections. The conversation highlights innovative approaches to using viruses as a therapeutic tool, offering hope for future cancer treatments.